Comparative Pharmacology
Head-to-head clinical analysis: BENZAMYCIN versus LOTUSATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BENZAMYCIN versus LOTUSATE.
BENZAMYCIN vs LOTUSATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
BENZAMYCIN (benzoyl peroxide and clindamycin) combines the keratolytic and antimicrobial actions of benzoyl peroxide with the antibacterial effect of clindamycin, a lincosamide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.
LOTUSATE is a selective serotonin reuptake inhibitor (SSRI) that inhibits the reuptake of serotonin at the presynaptic neuronal membrane, enhancing serotonin activity in the central nervous system and thereby exerting antidepressant and anxiolytic effects.
Topical: Apply a thin layer to affected areas twice daily (morning and evening). Each gram contains 30 mg benzoyl peroxide and 30 mg erythromycin.
100 mg orally twice daily, with or without food.
None Documented
None Documented
2.5-3.5 hours in adults with normal renal function; may be prolonged to 4-6 hours in patients with hepatic impairment
Terminal elimination half-life is 3.5-4.5 hours in healthy adults; prolonged to 8-10 hours in moderate hepatic impairment, requiring dose adjustment.
Renal excretion: ~70% (30% as unchanged drug, 40% as active metabolite N-desmethylclindamycin); biliary/fecal: ~30%
Primarily renal excretion of unchanged drug (65-75%) with 15-20% as glucuronide conjugate; 10-15% eliminated via feces.
Category C
Category C
Topical Antibiotic
Topical Antibiotic